11/13/2024
3:05 PM | ImmuCell (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/24/2024
10:55 AM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
7:29 AM | ImmuCell (Issuer)
Rosgen Steven T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:29 AM | Gathagan Bryan K. (Reporting)
ImmuCell (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:30 AM | ImmuCell (Issuer)
Tomsche David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:30 AM | Basse Gloria F (Reporting)
ImmuCell (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:31 AM | ImmuCell (Issuer)
Wainman Paul R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/17/2024
12:49 PM | ImmuCell (Subject)
SRK FUND I, LP (Filed by)
| Form SCHEDULE 13D/A | |
08/30/2024
11:25 AM | ImmuCell (Issuer)
Tomsche David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:32 PM | ImmuCell (Subject)
Knudsen Ejnar A III (Filed by)
| Form SC 13D | |
08/26/2024
2:00 PM | ImmuCell (Issuer)
Tomsche David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
12:05 PM | ImmuCell (Issuer)
Tomsche David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
12:04 PM | ImmuCell (Issuer)
Tomsche David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:05 PM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
12:38 PM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
10:33 AM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
6:49 AM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:50 PM | ImmuCell (Subject)
SRK FUND I, LP (Filed by)
| Form SCHEDULE 13D | |
05/14/2024
3:05 PM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:06 PM | ImmuCell (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
8:00 AM | ImmuCell (Filer)
| Form DEF 14A | |
04/09/2024
6:50 PM | ImmuCell (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/09/2024
6:52 PM | ImmuCell (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/09/2024
11:15 PM | ImmuCell (Filer)
| Form EFFECT | |
04/09/2024
4:19 PM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
12:55 PM | ImmuCell (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
